Inhalable Mucus-Penetrating Engineered Hybrid Nanomedicine for Enhanced Treatment of Idiopathic Pulmonary Fibrosis

Journal:
Nano Letters
Published:
DOI:
10.1021/acs.nanolett.5c02481
Affiliations:
3
Authors:
11
Go to article
Institutions Authors Share
MOE Key Laboratory for Ultrafine Materials, ECUST, China
6.000000
 0.55
Shanghai Pulmonary Hospital, China
3.000000
 0.27
Shanghai Ninth People's Hospital, SJTU, China
2.000000
 0.18
Interested in Pharmacology and Pharmaceutical Sciences?